13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q4 2017. See the latest, Q3 2026 →
Reported value
$10.11B
+26% on the quarter before
Positions
34
2 new, 5 sold out
Top 10
75.3%
of the value
Est. gain
+$466.4M
on stocks held all quarter
Est. return
+6.3%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, sized at quarter-end prices.
- Time Warner Inc~$740.9MNew, 0.0% → 7.3% of the portfolio+8,100,000 shares
- Pioneer Nat Res Co~$340.7MAdded, 0.1% → 3.4% of the portfolio+1,971,105 shares
- Allergan Plc~$251.2MAdded, 7.6% → 7.3% of the portfolio+1,535,797 shares
- Cardinal Health Inc~$157.5MAdded, 2.1% → 3.1% of the portfolio+2,570,000 shares
- Mckesson Corp~$134.1MAdded, 1.0% → 2.1% of the portfolio+860,000 shares
- Qorvo~$133.2MAdded, 7.9% → 7.2% of the portfolio+2,000,000 shares
- Amerisourcebergen Corp~$114.4MAdded, 0.2% → 1.3% of the portfolio+1,245,715 shares
- Twenty First Centy Fox Inc~$108.8MAdded, 6.3% → 7.6% of the portfolio+3,151,262 shares
- Twenty First Centy Fox Inc~$107.4MAdded, 2.4% → 3.6% of the portfolio+3,146,716 shares
- Amc Entmt Hldgs Inc~$21.7MAdded, 0.7% → 0.7% of the portfolio+1,434,639 shares
Largest sells
Since Q3 2017, sized at quarter-end prices.
- Dell Technologies Inc~$235.7MSold out, 2.9% → 0.0% of the portfolio−3,052,459 shares
- Pbf Energy Inc~$170.2MCut, 5.4% → 3.8% of the portfolio−4,800,000 shares
- Centennial Resource Dev Inc~$42.1MSold out, 0.5% → 0.0% of the portfolio−2,407,153 shares
- Avis Budget Group~$39.5MSold out, 0.5% → 0.0% of the portfolio−1,036,900 shares
- ChipMOS Technologies~$27.9MCut, 0.7% → 0.3% of the portfolio−1,577,887 shares
- Silver Run Acquisition~$21.9MSold out, 0.3% → 0.0% of the portfolio−2,149,352 shares
- Express Scripts Hldg Co~$18.7MCut, 2.0% → 1.7% of the portfolio−250,435 shares
- Forward Pharma A/S~$8.4MCut, 0.5% → 0.2% of the portfolio−2,283,325 shares
- Simply Good Foods Co~$2.5MSold out, 0.0% → 0.0% of the portfolio−1,035,146 shares
Holdings
As of Dec 31, 2017; changes in shares since Sep 30, 2017.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Synchrony FinlCOM · shares 0% · price +24.3% | 11.2% | $1.13B | +$221.5M | ||||||
| Cheniere Energy IncCOM NEW · shares 0% · price +19.5% | 11.0% | $1.12B | +$182.4M | ||||||
| Viasat IncCOM · shares 0% · price +16.4% | 9.7% | $984.9M | +$138.6M | ||||||
| Twenty First Centy Fox IncCL A · shares +16% · price +30.9% | 7.6% | $769.6M | +$156.0M | ||||||
| Time Warner IncCOM NEW · shares New | 7.3% | $740.9M | — | ||||||
| Allergan PlcSHS · shares +52% · price −20.2% | 7.3% | $736.1M | −$122.6M | ||||||
| QorvoCOM · shares +22% · price −5.8% | 7.2% | $732.6M | −$36.7M | ||||||
| Colony Northstar IncCL A COM · shares 0% · price −9.2% | 5.4% | $546.6M | −$55.1M | ||||||
| Antero Res CorpCOM · shares +3.4% · price −4.5% | 4.6% | $469.7M | −$21.5M | ||||||
| Pbf Energy IncCL A · shares −31% · price +28.4% | 3.8% | $387.3M | +$85.6M | ||||||
| Twenty First Centy Fox IncCL B · shares +43% · price +32.3% | 3.6% | $359.3M | +$61.5M | ||||||
| Pioneer Nat Res CoCOM · shares +6,822% · price +17.2% | 3.4% | $345.7M | +$731,501 | ||||||
| Cardinal Health IncCOM · shares +102% · price −8.4% | 3.1% | $312.5M | −$14.3M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price −18.5% | 2.6% | $259.6M | −$59.1M | ||||||
| Mckesson CorpCOM · shares +172% · price +1.5% | 2.1% | $212.1M | +$1.2M | ||||||
| Express Scripts Hldg CoCOM · shares −9.8% · price +17.9% | 1.7% | $172.2M | +$26.1M | ||||||
| Amerisourcebergen CorpCOM · shares +660% · price +11.0% | 1.3% | $131.7M | +$1.7M | ||||||
| Keryx Biopharmaceuticals IncCOM · shares 0% · price −34.5% | 1.2% | $119.9M | −$63.2M | ||||||
| Veritiv CorpCOM · shares +19% · price −11.1% | 1.0% | $105.2M | −$11.0M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price +9.4% | 0.96% | $97.0M | +$8.3M | ||||||
| Amc Entmt Hldgs IncCL A COM · shares +40% · price +2.7% | 0.75% | $75.5M | +$1.4M | ||||||
| Gty Technology Holdings IncUNIT 99/99/9999 · shares 0% · price −1.4% | 0.45% | $45.4M | −$645,000 | ||||||
| Paratek Pharmaceuticals IncCOM · shares 0% · price −28.7% | 0.42% | $42.9M | −$17.2M | ||||||
| Novagold Res IncCOM NEW · shares +13% · price −4.6% | 0.42% | $42.2M | −$1.8M | ||||||
| Theravance Biopharma IncNOTE 3.250%11/0 · shares 0% · price −11.0% | 0.33% | $33.0M | — | ||||||
| Total 34 positions | 100% | $10.11B | +$466.4M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 31 stocks held throughout, up $466.4M (+6.3%).
- Synchrony Finl+$221.5M+24%
- Cheniere Energy Inc+$182.4M+20%
- Twenty First Centy Fox Inc+$156.0M+31%
- Viasat Inc+$138.6M+16%
- Pbf Energy Inc+$85.6M+28%
- Qorvo−$36.7M−6%
- Colony Northstar Inc−$55.1M−9%
- Theravance Biopharma Inc−$59.1M−19%
- Keryx Biopharmaceuticals Inc−$63.2M−35%
- Allergan Plc−$122.6M−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |